Modular Medical (NASDAQ:MODD – Get Free Report) was downgraded by investment analysts at Wall Street Zen to a “strong sell” rating in a note issued to investors on Saturday.
Separately, Weiss Ratings reissued a “sell (e+)” rating on shares of Modular Medical in a research note on Wednesday, June 24th. One research analyst has rated the stock with a Sell rating, According to data from MarketBeat, the stock has a consensus rating of “Sell”.
Read Our Latest Stock Report on MODD
Modular Medical Stock Performance
Modular Medical (NASDAQ:MODD – Get Free Report) last issued its quarterly earnings data on Friday, August 14th. The company reported ($1.19) EPS for the quarter.
Institutional Investors Weigh In On Modular Medical
Several institutional investors and hedge funds have recently added to or reduced their stakes in MODD. Perritt Capital Management Inc boosted its stake in shares of Modular Medical by 34.2% during the 3rd quarter. Perritt Capital Management Inc now owns 85,000 shares of the company’s stock worth $59,000 after buying an additional 21,675 shares during the last quarter. Jane Street Group LLC raised its holdings in Modular Medical by 446.8% during the fourth quarter. Jane Street Group LLC now owns 163,952 shares of the company’s stock worth $60,000 after acquiring an additional 133,969 shares in the last quarter. 683 Capital Management LLC boosted its position in Modular Medical by 79.4% during the fourth quarter. 683 Capital Management LLC now owns 1,762,103 shares of the company’s stock valued at $642,000 after purchasing an additional 780,000 shares during the last quarter. Bleichroeder LP grew its stake in Modular Medical by 41.9% in the fourth quarter. Bleichroeder LP now owns 2,859,581 shares of the company’s stock valued at $1,041,000 after purchasing an additional 845,000 shares in the last quarter. Finally, AWM Investment Company Inc. increased its position in shares of Modular Medical by 20.3% during the 2nd quarter. AWM Investment Company Inc. now owns 441,095 shares of the company’s stock worth $1,985,000 after purchasing an additional 74,429 shares during the last quarter. 27.47% of the stock is owned by institutional investors.
Modular Medical Company Profile
Modular Medical, Inc operates as a medical device company. It focuses on the design, development, and commercialization of insulin pumps. It offers MODD1, a two-part patch pump for type-1 and type-2 diabetes. The company is headquartered in San Diego, California.
Recommended Stories
- Five stocks we like better than Modular Medical
- The Metals Company’s Big Bet Now Comes Down to a License
- OneSpaWorld Keeps Turning Cruise Demand Into Record Earnings
- Meta and Tesla Are Rebounding From Oversold Levels—Now What?
- AMG’s Alternatives Boom Powers Record Growth
Receive News & Ratings for Modular Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Modular Medical and related companies with MarketBeat.com's FREE daily email newsletter.
